The World Health Organization (WHO) has issued an urgent appeal to governments worldwide to prioritize and expand newborn screening programs, emphasizing that early detection of birth defects is a critical yet underutilized tool in reducing child mortality and preventing lifelong disabilities. In a comprehensive new report titled Strengthening capacity for newborn screening, diagnosis and management of birth defects, the global health body outlines a strategic framework for countries to integrate these life-saving interventions into their national health systems. The report highlights a growing disparity in child health outcomes, noting that while some nations offer comprehensive screening for dozens of conditions, millions of infants in low- and middle-income countries (LMICs) remain entirely underserved, often with fatal consequences.
According to WHO data, approximately 8 million babies are born with a birth defect every year. These conditions, which range from structural abnormalities to metabolic and genetic disorders, now account for nearly 8% of all deaths among children under the age of five. The burden of these conditions is overwhelmingly concentrated in resource-constrained environments; an estimated 90% of children born with serious birth defects reside in LMICs. In these regions, the lack of access to early screening and diagnostic services means that many conditions which are manageable or curable in high-income settings become death sentences or causes of permanent impairment.
The Critical Window for Early Intervention
The WHO report identifies newborn screening as a pivotal opportunity to accelerate global progress in child survival. Many congenital conditions, if identified within the first few days of life, can be treated effectively, allowing children to lead healthy, productive lives. Among the priority conditions highlighted are congenital hypothyroidism, which can lead to severe intellectual disability if untreated; sickle-cell disease, which requires early prophylactic care to prevent life-threatening infections; and various metabolic disorders that can be managed through dietary interventions.
Furthermore, the report emphasizes the importance of screening for sensory impairments, such as hearing loss. Early identification of hearing impairment allows for timely interventions, including hearing aids or cochlear implants and speech therapy, which are essential for a child’s linguistic and cognitive development. Despite the availability of cost-effective technologies for these screenings, the WHO warns that millions of children are still diagnosed too late or never receive any form of medical intervention.
Dr. Tedros Adhanom Ghebreyesus, WHO Director-General, underscored the moral and medical imperative of universal screening. "No child should miss the chance for a healthy future because a congenital condition was not detected early enough," Dr. Tedros stated. He noted that the disparity between nations is "stark," with some countries screening for more than 50 conditions while others lack any infrastructure for neonatal testing. The WHO’s recommendation is for every country to initiate screening for at least one high-priority condition relevant to its specific population and to progressively expand these services as healthcare capacity matures.
A Shifting Landscape in Child Mortality
The urgency of the WHO’s call is underscored by a significant shift in global health trends. As deaths from infectious diseases, malnutrition, and poor sanitation have declined over the past two decades due to successful public health campaigns, birth defects have emerged as a more prominent cause of child mortality.
Between 2000 and 2023, the proportion of under-five deaths attributable to birth defects rose significantly in several regions. In sub-Saharan Africa, the figure increased from 1% to 4%, while in South Asia, it jumped from 3% to 11%. While these statistics partially reflect the success of interventions against pneumonia, diarrhea, and malaria, they also highlight a critical gap in neonatal care. As countries transition through different stages of the epidemiological shift, the management of non-communicable and congenital conditions becomes the next frontier in improving child survival rates.
The WHO report aims to provide health ministries, particularly in LMICs, with the technical guidance necessary to navigate this transition. It suggests that by prioritizing conditions based on local prevalence and the feasibility of treatment, countries can maximize the impact of their investments in newborn health.
Global Models of Success
The report showcases several countries across diverse geographic and economic landscapes that have successfully integrated large-scale newborn screening into their routine health services. These case studies serve as a blueprint for nations looking to establish or expand their own programs.
In India, the national health program has demonstrated the power of scale. Over a three-year period, the country screened more than 28 million children. This massive effort identified approximately 900,000 children with birth defects, all of whom were subsequently connected to diagnostic, treatment, and rehabilitation services through a network of district early intervention centers. This model illustrates how a high-burden country can leverage existing primary healthcare infrastructure to reach millions.
The Philippines offers a model for legislative and financial sustainability. What began as a pilot program in 24 hospitals has evolved into a nationwide mandate. Today, more than 7,000 facilities across the Philippines screen newborns for 29 different conditions. Crucially, the program is mandated by law and covered by national health insurance, ensuring that screening and subsequent management are accessible to all families regardless of their socioeconomic status.
Other notable examples include:
- Argentina and Brazil: Both South American nations have achieved nearly universal screening coverage, expanding their programs to include a wide array of life-threatening conditions.
- Egypt: The government has successfully integrated universal screening for hearing loss and congenital hypothyroidism into its primary healthcare "newborn care pathway."
- Sri Lanka: Approximately 80% of newborns in Sri Lanka are now screened for congenital hypothyroidism, with the service fully integrated into routine neonatal care.
- Uganda: In regions with a high prevalence of sickle-cell disease, the state has implemented a targeted screening program that identifies affected infants early, providing them with the specialized care and long-term follow-up necessary to survive into adulthood.
Integration into Universal Health Coverage
A central theme of the WHO’s advocacy is the integration of newborn screening into the broader framework of Universal Health Coverage (UHC). The organization argues that screening should not be viewed as a standalone luxury but as a fundamental component of a comprehensive health system. For screening to be effective, it must be linked to a robust "continuum of care" that includes confirmatory diagnosis, medical treatment, and long-term support services.
The WHO urges governments to ensure that screening programs are equity-driven. In many regions, the children most at risk of birth defects—those born into poverty or in remote areas—are the least likely to be screened. By embedding these services into routine maternal and child health programs, governments can ensure that the most vulnerable populations are reached.
The development of this report was the result of extensive global consultation. The WHO brought together a diverse group of stakeholders, including government officials, technical experts, clinicians, researchers, and civil society organizations. Significantly, families affected by birth defects played a key role in identifying the priorities for long-term care and rehabilitation, ensuring that the report reflects the lived realities of those navigating these conditions.
Economic and Social Implications
Beyond the immediate health benefits, the expansion of newborn screening carries significant socioeconomic implications. Untreated birth defects often lead to lifelong disabilities that require intensive care, placing a heavy financial and emotional burden on families and straining national social safety nets. Children with undetected hearing loss or metabolic disorders may face barriers to education and future employment, limiting their ability to contribute to the economy.
By investing in early detection, countries can mitigate these long-term costs. Early intervention is frequently more cost-effective than managing the complications of advanced disease or providing lifelong support for preventable disabilities. The WHO’s analysis suggests that for many conditions, the "return on investment" for screening is substantial, making it a sound economic policy as well as a public health priority.
Looking Toward the Future
As the global health community looks toward the middle of the decade, the WHO is positioning newborn screening as a cornerstone of its 2026 agenda. The theme for World Health Day 2026, "Together for health. Stand with science," will serve as the launchpad for a year-long campaign to highlight science-based interventions as the foundation of global well-being.
The WHO’s mission remains focused on supporting all countries to promote, provide, and protect health. By advocating for the expansion of newborn screening, the organization seeks to ensure that the 8 million children born with birth defects each year are not forgotten. The path forward requires political will, sustainable funding, and a commitment to scientific rigor, but the potential reward is a generation of children who are given the best possible start in life, regardless of where they are born.
The report concludes that while the challenges of implementing universal screening in resource-limited settings are significant, they are not insurmountable. Through phased implementation, international cooperation, and a focus on the most prevalent local conditions, every nation can take the first steps toward a future where no child is left behind due to a preventable or manageable congenital condition.
